CHEST 2023 On Demand Pass-Severity and Outcomes of Disease in Pulmonary Vascular Disease

Video Transcription

Video Summary

The study discussed the impact of cardiovascular complications in patients with systemic sclerosis-induced pulmonary hypertension. The objective was to identify the prevalence of cardiovascular complications in these patients and assess their impact on prognosis. The study used the National Inpatient Database to identify patients with systemic sclerosis-induced pulmonary hypertension and analyzed their clinical and demographic data. The findings showed that patients with pulmonary hypertension had a higher prevalence of conduction disorder and tachyarrhythmias compared to patients without pulmonary hypertension. The study also found that these patients had a higher risk of acute heart failure. However, multivariate analysis did not demonstrate a significant correlation between pulmonary arterial hypertension and acute heart failure. The study concluded that pulmonary hypertension in systemic sclerosis patients is associated with a higher prevalence of conduction disorder and tachyarrhythmias. The likely etiology is structural damage and myocardial fibrosis. The study suggests that regular cardiovascular monitoring and dedicated cardiovascular screening guidelines are recommended in patients with systemic sclerosis, especially after the emergence of pulmonary hypertension, to prevent mortality and morbidity.

Meta Tag

Category Pulmonary Vascular Disease

Session ID 4035

Speaker Saif Abu-Baker

Speaker Ruhma Ali

Speaker Michael Goulet

Speaker Kaushik Kumar

Speaker Smitesh Padte

Speaker Arsal Tharwani

Track Pulmonary Vascular Disease

Keywords

cardiovascular complications

systemic sclerosis

pulmonary hypertension

prevalence

conduction disorder

tachyarrhythmias

acute heart failure

PH